Chameleon Peptides closed on September 27, 2026. It told customers the reason in plain terms: Visa had sent notices to its underwriting banks questioning whether its sales were reaching only research customers, and the company decided the attestations it relied on were no longer enough. A farewell email followed on October 1, and the storefront now reads "Chameleon Peptides is Closed."
For buyers who chose Chameleon for its Janoshik-tested batches, two things matter now: getting the documentation out of the account before the login disappears, and choosing a replacement that matches the testing standard. This article covers both.
Research-context information only. Compounds discussed below are research peptides and supplements; some are investigational drugs not approved by the FDA. Protocols, doses, and reactions reported come from published research and self-reported community sources. Possession or use of investigational drugs outside an authorized clinical trial may be illegal in your jurisdiction. This article reports what has been documented, not what should be done. Consult a licensed physician for personal medical decisions.
Key Takeaways
- Chameleon announced its closure on September 27, 2026 and sent a farewell email on October 1. New purchases and new account registration are disabled.
- The stated cause was card-network scrutiny, not quality. Per the customer email reported by CompoundReview, Visa questioned whether sales were reaching only research customers.
- The customer archive is still live. We confirmed on October 6 that the closure page still offers an existing-customer sign-in for order history and lab reports. Save COAs now.
- A lookalike domain exists.
chameleonspeptides.com(extra "s") was registered August 3, 2026. We found no connection to the original company. - Six tracked vendors still ship the same catalog, all with batch COA documentation.
What Chameleon Peptides Was
Chameleon was a young vendor. Its domain was registered in October 2025, so it operated for roughly a year. It built a following quickly on one thing: verification. Batches carried vial-level identifiers with QR codes linking to Janoshik Analytical results, and independent COA trackers matched its published certificates against issuer records. Its Trustpilot profile showed a rating near 5.0 across several hundred reviews as of late September 2026.
The catalog was mid-sized. An August 27, 2026 archive of its shop page lists 42 products across tissue (BPC-157, TB-500, KPV), growth (tesamorelin, ipamorelin, sermorelin), longevity (GHK-Cu, SS-31, selank, semax, DSIP, thymosin alpha-1), reproductive (PT-141, kisspeptin, melanotan) and metabolic categories. The metabolic line used code names: CP-1S, CP-2T, CP-3R and CP-1C, following the common industry convention for semaglutide, tirzepatide, retatrutide and cagrilintide. Our vendor code names guide maps those conventions across sellers.
What former customers are replacing is not a catalog. Many vendors carry those compounds. They are replacing a documentation standard.
Why Did Chameleon Peptides Shut Down?
Most vendor closures come with no explanation. This one came with a specific reason, in the company's own words to customers.
Visa questioned its sales. According to Chameleon's September 27 email, as documented by CompoundReview, its underwriting banks (the acquiring banks that process card payments for a merchant) received notices from Visa questioning whether Chameleon's sales were reaching only research customers.
Attestations were not enough. Chameleon relied on buyers confirming research status and institutional affiliation at checkout. The company concluded those attestations were "no longer sufficient in the current compliance environment."
It wound down rather than fight. Instead of moving to a riskier processor, Chameleon stopped selling to new customers, disabled card payments, and sold remaining stock to existing account holders at 50% off, by Bitcoin and Zelle only.
This was not an FDA action, a lawsuit, or a quality failure. It was a payment-network decision. That makes it different from the 2025-2026 closures driven by enforcement or litigation, and it points to a pressure that applies across the category, not to one company. For the full closure record, see Every Peptide Vendor That Shut Down (2025-2026).
Save Your Chameleon COAs Now
This is the time-sensitive part, and the closure page itself makes it easy to miss.
The homepage says new purchases are closed, but it still offers an existing-customer sign-in described as giving access to "order history and lab reports." We confirmed it was live on October 6. Customers with past Chameleon orders can still sign in and download:
- Batch COAs and lab reports for every lot on hand, as PDFs or screenshots
- Order history and receipts, which matter for any refund or dispute
- Batch identifiers from vial labels, matched to their certificates
Once the domain lapses, there is no support desk to re-request documents from. A vial without its COA is a vial that can no longer be documented. The support address on the closure page is the route for open orders.
What to Look For in a Replacement
Chameleon customers chose it for verification, so that is the bar. Four things separate a real replacement from a site built to catch displaced traffic:
Batch-level third-party COAs. Documentation tied to a lot number and test date from a named independent lab, not one certificate reused across every batch of a product.
A track record longer than Chameleon's. Twelve-plus months of consistent operation and shipping. Chameleon's own one-year run shows that a strong reputation can form quickly and still end abruptly.
Transparent pricing. Per-vial prices with milligram strength stated plainly, so per-mg cost is calculable.
Stable checkout. After a closure triggered by card processing, payment options are a fair thing to check. Vendors whose checkout changes often, or who push buyers toward non-refundable payment methods, offer less recourse if an order goes wrong.
6 Vendors Still Shipping
We rank vendors on a weighted model: price 40%, COA documentation 30%, reputation 30%, with a floor score of 8.0. Every vendor below has operated for 12+ months and is tracked continuously rather than reviewed once.
The Peptide Catalog earns a commission when you buy through the vendor links on this page, at no extra cost to you.
The compounds discussed below are sold by these vendors as research chemicals not for human consumption. Several, including retatrutide and cagrilintide, are investigational with no FDA-approved indication.
